Protagonist Therapeutics (PTGX) PT Raised to $190 at BMO Capital
(Updated - September 1, 2026 9:09 AM EDT)
BMO Capital analyst Evan David Seigerman raised the price target on ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
BMO Capital analyst Evan David Seigerman raised the price target on ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
